Chair, Anthony R. Mato, MD, MSCE, Kristen Battiato, MSN, RN, AGNP-C, Dipti Gupta, MD, MPH, and Amber C. King, PharmD, BCOP, prepared useful Practice Aids pertaining to B-cell cancers for this CME/MOC/NCPD activity titled “Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD information, and to apply for credit, please visit us at http://bit.ly/3cHX3zm. CME/MOC/NCPD credit will be available until October 3, 2023.
Chair, Anthony R. Mato, MD, MSCE, Kristen Battiato, MSN, RN, AGNP-C, Dipti Gupta, MD, MPH, and Amber C. King, PharmD, BCOP, prepared useful Practice Aids pertaining to B-cell cancers for this CME/MOC/NCPD activity titled “Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD information, and to apply for credit, please visit us at http://bit.ly/3cHX3zm. CME/MOC/NCPD credit will be available until October 3, 2023.
Kshivets O. Esophageal & Cardioesophageal Cancer SurgeryOleg Kshivets
ADJUVANT CHEMOIMMUNORADIO/CHEMOIMMUNOTHERAPY SIGNIFICANTLY IMPROVED 5-YEAR SURVIVAL OF ESOPHAGEAL/CARDIOESOPHAGEAL CANCER PATIENTS AFTER RADICAL SURGERY
Dr. David Vesole, Co-Chief, Multiple Myeloma at John Theurer Cancer Center at HackensackUMC presentation at the MMRF Clinical Insights program in April 2012.
Kshivets O. Cardioesophageal Cancer SurgeryOleg Kshivets
ARTFICIAL INTELLIGENCE, SYSTEM ANALYSIS AND SIMULATION MODELING IN PREDICTION OF 5-YEAR SURVIVAL OF CARDIOESOPHAGEAL CANCER PATIENTS AFTER COMPLETE LEFT THORACOABDOMINAL ESOPHAGOGASTRECTOMIES
5-Year Survival of Lung Cancer Patients after Radical Surgery was Significantly Depended on Tumor Characteristics, Blood Cell Circuit, Cell Ratio Factors, Hemostasis System, Biochemic Homeostasis, Surgery Type, Adjuvant Treatment and Anthropometric Data
Kshivets O. Esophageal & Cardioesophageal Cancer SurgeryOleg Kshivets
ADJUVANT CHEMOIMMUNORADIO/CHEMOIMMUNOTHERAPY SIGNIFICANTLY IMPROVED 5-YEAR SURVIVAL OF ESOPHAGEAL/CARDIOESOPHAGEAL CANCER PATIENTS AFTER RADICAL SURGERY
Dr. David Vesole, Co-Chief, Multiple Myeloma at John Theurer Cancer Center at HackensackUMC presentation at the MMRF Clinical Insights program in April 2012.
Kshivets O. Cardioesophageal Cancer SurgeryOleg Kshivets
ARTFICIAL INTELLIGENCE, SYSTEM ANALYSIS AND SIMULATION MODELING IN PREDICTION OF 5-YEAR SURVIVAL OF CARDIOESOPHAGEAL CANCER PATIENTS AFTER COMPLETE LEFT THORACOABDOMINAL ESOPHAGOGASTRECTOMIES
5-Year Survival of Lung Cancer Patients after Radical Surgery was Significantly Depended on Tumor Characteristics, Blood Cell Circuit, Cell Ratio Factors, Hemostasis System, Biochemic Homeostasis, Surgery Type, Adjuvant Treatment and Anthropometric Data
A branch of medicine dealing with diseases and metabolic disorders that affect mitochondria. Focusing on diagnosing and treatment of wide range of these diseases. The symptom of these diseases varies from metabolic-induced developmental delay to complex problems that involve many body systems.
Present and Future Impact of Cytogenetics on Acute Myeloid Leukemialarriva
Cytogenetics is an advancement in which clinicians can look for specific genetic mutations of chromosomal DNA and use that information to determine patient prognosis and individualize therapy. In this presentation I cover what cytogenetics are, how they impact patient risk, what therapies to use based on risk, and how genetically targeted agents may be used in the future.
This is a PDF of a presentation given to the Radiation Oncology department at the University of Minnesota in October 2015. This PDF focuses on evaluation, management, and state-of-the-art approach to gliomas from a medical neuro-oncology perspective.
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...bkling
Patricia Steeg, PhD, Chief of Women's Cancers Section at the Center for Cancer Research at NCI, will present her novel research relating to metastatic breast cancer, including the development of experimental models of brain metastasis. Join SHARE and Dr. Steeg for this nformative webinar.
tranSMART Community Meeting 5-7 Nov 13 - Session 1: Translational Drug Disco...David Peyruc
tranSMART Community Meeting 5-7 Nov 13 - Session 1:
Translational Drug Discovery - Transforming Science into Medicine
Current challenges in translational Drug Discovery at Sanofi R&D
Andy Plump, Sanofi
Dr. José Baselga - Simposio Internacional 'Terapias oncológicas avanzadas'Fundación Ramón Areces
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
di Giampaolo Merlini, Centro per lo Studio e la Cura delle Amiloidosi Sistemiche, Fondazione IRCCS Policlinico San Matteo, Dipartimento di Medicina Molecolare Università di Pavia.
Slide per l'intervento tenuto in Fondazione Giannino Bassetti in occasione del primo incontro del ciclo "La medicina di precisione", primo progetto dalla convenzione tra Università di Pavia e Fondazione Bassetti.
12 marzo 2018
Similar to Medical Imaging In Future Physician (20)
1. Barnard Institute of Radiology & Oncology , Madras Medical College & Government General Hospital, and Advanced Nuclear Medicine Research Institute , Chennai. E. Mail – dreprabhu@gmail.com Medical Imaging in Future – Physician’s Perspectives Dr. E. Prabhu, M.D.(Gen. Medicine), D.R.M., FIMSA Nuclear Medicine Physician, E.C. member, SNM (India) & NABH Assessor for Medical Imaging 15 th August, 2010
2. Internal Medicine has always attracted the best students, has prestige, poses intellectual challenge and promises full patient care. Challenges faced by the Current Physician There fore we need periodic up-dates in Technical advances in genetics and molecular biology Medical Imaging, Computers and their role in Clinical Decision Making Political, Economic & Life- style challenges in modern society
3. Currently, we do not focus only on the causes of our patient’s problems. Instead, we search for modifiable molecular manifestations of the problems in terms of location, structure, function & biochemistry. Principles of Current Medical Imaging
4. K Shell L Shell M Shell DNA Strand Options in Medical Imaging includes the Digital Radiography, Ultrasound, the Computed Tomography, Optical Imaging, Magnetic Resonance & Functional MR, the SPECT / PET and the PACS for Image Archiving and Communication
5. Clerca. J et al; Scintigraphic Imaging of Paediatric Thyroid Dysfunction, Horm Res (2008);70:1-13 There are about 20,000 different types of molecules in the body. Either these molecules send wrong messages are don’t receive right messages. Recognition of the molecules is the basic for diseases. … functions are fast processes of short duration, while structures are slow processes of long duration …
6. Technological Advances in Medicine for Diagnosis and Treatment are Less Invasive, Precise and Objective Modern Medical Imaging helps in Integration and Weighing of Complex Clinical information This helps us to take Leadership position in Medicine by interpreting bewildering array of information and making wise Clinical decisions
9. Spinal Metastasis & Metastatic Disease to the Spine & Related Structures Approximately 94-98% of these patients present with epidural and/or vertebral involvement. Intradural extramedullary and intramedullary seeding of systemic cancer is unusual; they account for 5-6% and 0.5-1% of spinal metastases, respectively. Patil et al. National inpatient complications and outcomes after surgery for spinal metastasis from 1993-2002. Cancer. Aug 1 2007;110(3):625-30.
22. Then Dawn of Fusion & Multidisciplinary Medical Imaging ...and borrowing ideas from Radioastronomy..
23. PET MRI CT PET-MRI PET-CT PET-CT-MRI Receptors, enzymes, membrane transporters and Signal transduction proteins in renal diseases, Tissue Hypoxia and Apoptosis in renovascular disease and in obstruction Endothelial dysfunction and assessment of molecular response to drugs and atherosclerosis; Drug delivery systems based on anion, cation, glucose and peptide transporters Reporter gene therapy and monitoring rejection, Targeting receptors, oncoproteins, growth factors and cytokines Anatomical and Functional Renal Images PET+CT+MRI
24.
25. Current trends in Molecular Imaging 131 I Whole Body Scan 124 I Whole Body PET Scan 18 F - FDG Whole Body PET Scan
33. 'The wisdom of the Prudent is to Understand His way...' Current Research in Medicine and Medical Imaging
34. ‘ ....in future, diagnoses will be molecular, treatment will be molecular, and monitoring the response to treatment will be molecular...’ . 1970 2010 Thank You Personalized Medicine